Last 12 months
Inside the activity.
0 purchase rows · 74 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 13 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 3 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 15 |
| Jul 2026 | 0 | 12 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 6 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 27, 2024 Filed Mar 29, 2024 21:59 UTC |
Hohl BenjaminCHIEF FINANCIAL OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,250 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001415889-24-009450 · form4-03292024_090320.xml · derivative · entry 4 Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 239,370 Underlying: Common Stock · 3,250 shares Expires 2031-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F4 · derivative.exercise_date: The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| March 27, 2024 Filed Mar 29, 2024 21:59 UTC |
Hohl BenjaminCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 182 | $18.72 | $3,406.79 |
DisclosureSEC source: 0001415889-24-009450 · form4-03292024_090320.xml · nonDerivative · entry 3 Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $18.69 to $18.755. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| March 27, 2024 Filed Mar 29, 2024 21:59 UTC |
Hohl BenjaminCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 3,068 | $18.22 | $55,895.59 |
DisclosureSEC source: 0001415889-24-009450 · form4-03292024_090320.xml · nonDerivative · entry 2 Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 182 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $17.69 to $18.66. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| March 27, 2024 Filed Mar 29, 2024 21:59 UTC |
Hohl BenjaminCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 3,250 | $2.48 | $8,060.00 |
DisclosureSEC source: 0001415889-24-009450 · form4-03292024_090320.xml · nonDerivative · entry 1 Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 17:03 UTC |
Kintz SamuelDirector · PRESIDENT AND CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001415889-24-009220 · form4-03272024_090352.xml · derivative · entry 7 Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 260,550 Underlying: Common Stock · 12,000 shares Expires 2030-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F7 · derivative.exercise_date: The option, originally for 344,550 shares, is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on May 3, 2020. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 17:03 UTC |
Kintz SamuelDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 4,671 | $18.16 | $84,841.24 |
DisclosureSEC source: 0001415889-24-009220 · form4-03272024_090352.xml · nonDerivative · entry 3 Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $17.96 to $18.80. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 17:03 UTC |
Kintz SamuelDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 7,329 | $17.17 | $125,819.87 |
DisclosureSEC source: 0001415889-24-009220 · form4-03272024_090352.xml · nonDerivative · entry 2 Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,671 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $16.90 to $17.59. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 17:03 UTC |
Kintz SamuelDirector · PRESIDENT AND CEO
|
Exercise / conversionCommon Stock | 12,000 | $1.12 | $13,440.00 |
DisclosureSEC source: 0001415889-24-009220 · form4-03272024_090352.xml · nonDerivative · entry 1 Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 23:46 UTC |
Ballal Rahul D.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 13,278 | $0.00 Strike: $5.52 | $0.00 |
DisclosureSEC source: 0001415889-24-009019 · form4-03222024_110316.xml · derivative · entry 3 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,571 Underlying: Common Stock · 13,278 shares Expires 2032-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. F4 · derivative.exercise_date: The option, originally for 32,849 shares, which share amount reflects the Stock Split, vested as to one-fourth of the shares on January 28, 2023, and the remainder of the shares vest in 12 equal quarterly installments thereafter. F2 · balance_after: The number of shares beneficially owned (i) reflects the 1-for-4 reverse stock split of the Issuer's Common Stock effected February 23, 2023 (the "Stock Split") and (ii) has been adjusted following an internal review of the Reporting Person's holdings. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 23:46 UTC |
Ballal Rahul D.Director
|
SaleCommon Stock | 13,278 | $19.16 | $254,462.25 |
DisclosureSEC source: 0001415889-24-009019 · form4-03222024_110316.xml · nonDerivative · entry 2 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,341 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $19.005 to $19.405. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 23:46 UTC |
Ballal Rahul D.Director
|
Exercise / conversionCommon Stock | 13,278 | $5.52 | $73,294.56 |
DisclosureSEC source: 0001415889-24-009019 · form4-03222024_110316.xml · nonDerivative · entry 1 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. F2 · balance_after: The number of shares beneficially owned (i) reflects the 1-for-4 reverse stock split of the Issuer's Common Stock effected February 23, 2023 (the "Stock Split") and (ii) has been adjusted following an internal review of the Reporting Person's holdings. Read SEC document |
| March 19, 2024 Filed Mar 21, 2024 22:41 UTC |
Heyman Richard A.Director
|
SaleCommon Stock | 1,270 | $14.50 | $18,418.68 |
DisclosureSEC source: 0001415889-24-008883 · form4-03212024_100359.xml · nonDerivative · entry 1 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 143,470 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 17, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $14.50 to $14.725. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| March 06, 2024 Filed Mar 9, 2024 00:52 UTC |
Patel AnishCHIEF OPERATING OFFICER
|
SaleCommon Stock | 4,875 | $15.64 | $76,238.66 |
DisclosureSEC source: 0001415889-24-007457 · form4-03092024_120325.xml · nonDerivative · entry 1 Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,472 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.19 to $15.97. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 17:55 UTC |
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001415889-24-006358 · form4-03042024_100311.xml · derivative · entry 5 Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 272,550 Underlying: Common Stock · 12,000 shares Expires 2030-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F5 · derivative.exercise_date: The option, originally for 344,550 shares, is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on May 3, 2020. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 17:55 UTC |
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 1,805 | $17.09 | $30,854.31 |
DisclosureSEC source: 0001415889-24-006358 · form4-03042024_100311.xml · nonDerivative · entry 3 Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $16.86 to $17.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 17:55 UTC |
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 10,195 | $16.30 | $166,151.99 |
DisclosureSEC source: 0001415889-24-006358 · form4-03042024_100311.xml · nonDerivative · entry 2 Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,805 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.86 to $16.85. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 17:55 UTC |
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
|
Exercise / conversionCommon Stock | 12,000 | $1.12 | $13,440.00 |
DisclosureSEC source: 0001415889-24-006358 · form4-03042024_100311.xml · nonDerivative · entry 1 Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 22:27 UTC |
Hohl BenjaminCHIEF FINANCIAL OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,250 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001415889-24-005930 · form4-02292024_100247.xml · derivative · entry 3 Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 242,620 Underlying: Common Stock · 3,250 shares Expires 2031-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F3 · derivative.exercise_date: The option, originally for 262,120 shares, vested as to one-fourth of the shares vests on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 22:27 UTC |
Hohl BenjaminCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 3,250 | $16.97 | $55,162.90 |
DisclosureSEC source: 0001415889-24-005930 · form4-02292024_100247.xml · nonDerivative · entry 2 Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $16.60 to $17.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 22:27 UTC |
Hohl BenjaminCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 3,250 | $2.48 | $8,060.00 |
DisclosureSEC source: 0001415889-24-005930 · form4-02292024_100247.xml · nonDerivative · entry 1 Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 17:14 UTC |
Kintz SamuelDirector · PRESIDENT AND CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001415889-24-005748 · form4-02282024_100201.xml · derivative · entry 7 Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 272,550 Underlying: Common Stock · 12,000 shares Expires 2030-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F7 · derivative.exercise_date: The option, originally for 344,550 shares, is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on May 3, 2020. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 17:14 UTC |
Kintz SamuelDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 4,376 | $17.24 | $75,434.80 |
DisclosureSEC source: 0001415889-24-005748 · form4-02282024_100201.xml · nonDerivative · entry 3 Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $17.00 to $17.56. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 17:14 UTC |
Kintz SamuelDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 7,624 | $16.69 | $127,218.64 |
DisclosureSEC source: 0001415889-24-005748 · form4-02282024_100201.xml · nonDerivative · entry 2 Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,376 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $16.00 to $16.96. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 17:14 UTC |
Kintz SamuelDirector · PRESIDENT AND CEO
|
Exercise / conversionCommon Stock | 12,000 | $1.12 | $13,440.00 |
DisclosureSEC source: 0001415889-24-005748 · form4-02282024_100201.xml · nonDerivative · entry 1 Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:41 UTC |
Heyman Richard A.Director
|
SaleCommon Stock | 1,270 | $17.42 | $22,117.43 |
DisclosureSEC source: 0001415889-24-004495 · form4-02212024_120234.xml · nonDerivative · entry 1 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 144,740 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 17, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $17.25 to $17.74. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:15 UTC |
5AM Partners VI, LLC10% owner
5AM Ventures VI, L.P.10% owner
5AM Opportunities I (GP), LLC10% owner
5AM Opportunities I, L.P.10% owner
PARMAR KUSH10% owner
Schwab Andrew J.10% owner
|
SaleCommon Stock | 136,642 | $14.90 | $2,035,965.80 |
DisclosureSEC source: 0001415889-24-004111 · form4-02162024_040204.xml · nonDerivative · entry 2 5AM Partners VI, LLC · CIK 0001829051 · 10% owner 5AM Ventures VI, L.P. · CIK 0001753037 · 10% owner 5AM Opportunities I (GP), LLC · CIK 0001790778 · 10% owner 5AM Opportunities I, L.P. · CIK 0001753000 · 10% owner PARMAR KUSH · CIK 0001664281 · 10% owner Schwab Andrew J. · CIK 0001598549 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By 5AM Opportunities I, L.P. Disclosed balance after: 635,341 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.89 to $14.93 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The shares are directly held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are the managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Dr. Parmar and Mr. Schwab disclaims beneficial ownership of such shares, except to the extent of its or his respective pecuniary interest therein. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:15 UTC |
5AM Partners VI, LLC10% owner
5AM Ventures VI, L.P.10% owner
5AM Opportunities I (GP), LLC10% owner
5AM Opportunities I, L.P.10% owner
PARMAR KUSH10% owner
Schwab Andrew J.10% owner
|
SaleCommon Stock | 688,358 | $14.90 | $10,256,534.20 |
DisclosureSEC source: 0001415889-24-004111 · form4-02162024_040204.xml · nonDerivative · entry 1 5AM Partners VI, LLC · CIK 0001829051 · 10% owner 5AM Ventures VI, L.P. · CIK 0001753037 · 10% owner 5AM Opportunities I (GP), LLC · CIK 0001790778 · 10% owner 5AM Opportunities I, L.P. · CIK 0001753000 · 10% owner PARMAR KUSH · CIK 0001664281 · 10% owner Schwab Andrew J. · CIK 0001598549 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By 5AMVentures VI, L.P. Disclosed balance after: 3,200,634 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.89 to $14.93 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: The shares are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VI and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VI. Each of Partners VI, Dr. Parmar and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:00 UTC |
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
|
GrantStock Option (right to buy) · Derivative | 185,000 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001415889-24-004024 · form4-02162024_020217.xml · derivative · entry 1 Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,000 Underlying: Common Stock · 185,000 shares Expires 2034-02-12 F1 · derivative.exercise_date: 1/4th of the shares subject to the option will vest on February 13, 2025 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 20:56 UTC |
Kintz SamuelDirector · PRESIDENT AND CEO
|
GrantStock Option (right to buy) · Derivative | 410,000 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001415889-24-004022 · form4-02162024_010204.xml · derivative · entry 1 Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410,000 Underlying: Common Stock · 410,000 shares Expires 2034-02-12 F1 · derivative.exercise_date: 1/4th of the shares subject to the option will vest on February 13, 2025 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 01:48 UTC |
Derynck Mika KDirector
|
GrantStock Option (right to buy) · Derivative | 16,835 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001415889-24-004014 · form4-02162024_010234.xml · derivative · entry 1 Derynck Mika K · CIK 0001865125 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,835 Underlying: Common Stock · 16,835 shares Expires 2034-02-12 F1 · derivative.exercise_date: 100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2024 annual meeting of the Issuer's stockholders or (ii) the date of the 2025 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 01:41 UTC |
Ballal Rahul D.Director
|
GrantStock Option (right to buy) · Derivative | 16,835 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001415889-24-004006 · form4-02162024_010242.xml · derivative · entry 1 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,835 Underlying: Common Stock · 16,835 shares Expires 2034-02-12 F1 · derivative.exercise_date: 100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2024 annual meeting of the Issuer's stockholders or (ii) the date of the 2025 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 02:04 UTC |
Phillips Andrew JohnDirector
|
GrantStock Option (right to buy) · Derivative | 16,835 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001415889-24-004028 · form4-02162024_020201.xml · derivative · entry 1 Phillips Andrew John · CIK 0001921956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,835 Underlying: Common Stock · 16,835 shares Expires 2034-02-12 F1 · derivative.exercise_date: 100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2024 annual meeting of the Issuer's stockholders or (ii) the date of the 2025 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 02:02 UTC |
Patel AnishCHIEF OPERATING OFFICER
|
GrantStock Option (right to buy) · Derivative | 185,000 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001415889-24-004026 · form4-02162024_020214.xml · derivative · entry 1 Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,000 Underlying: Common Stock · 185,000 shares Expires 2034-02-12 F1 · derivative.exercise_date: 1/4th of the shares subject to the option will vest on February 13, 2025 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 01:54 UTC |
Hohl BenjaminCHIEF FINANCIAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 185,000 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001415889-24-004020 · form4-02162024_010205.xml · derivative · entry 1 Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,000 Underlying: Common Stock · 185,000 shares Expires 2034-02-12 F1 · derivative.exercise_date: 1/4th of the shares subject to the option will vest on February 13, 2025 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 01:52 UTC |
Heyman Richard A.Director
|
GrantStock Option (right to buy) · Derivative | 21,043 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001415889-24-004018 · form4-02162024_010226.xml · derivative · entry 1 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,043 Underlying: Common Stock · 21,043 shares Expires 2034-02-12 F1 · derivative.exercise_date: 100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2024 annual meeting of the Issuer's stockholders or (ii) the date of the 2025 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 01:50 UTC |
Gupta RishiDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 16,835 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001415889-24-004016 · form4-02162024_010218.xml · derivative · entry 1 Gupta Rishi · CIK 0001537370 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,835 Underlying: Common Stock · 16,835 shares Expires 2034-02-12 F1 · derivative.exercise_date: 100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2024 annual meeting of the Issuer's stockholders or (ii) the date of the 2025 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 01:46 UTC |
Collins Helen LouiseCHIEF MEDICAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 185,000 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001415889-24-004012 · form4-02162024_010221.xml · derivative · entry 1 Collins Helen Louise · CIK 0001701247 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,000 Underlying: Common Stock · 185,000 shares Expires 2034-02-12 F1 · derivative.exercise_date: 1/4th of the shares subject to the option will vest on February 13, 2025 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 01:44 UTC |
Bauer JakeDirector
|
GrantStock Option (right to buy) · Derivative | 16,835 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001415889-24-004010 · form4-02162024_010212.xml · derivative · entry 1 Bauer Jake · CIK 0001654909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,835 Underlying: Common Stock · 16,835 shares Expires 2034-02-12 F1 · derivative.exercise_date: 100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2024 annual meeting of the Issuer's stockholders or (ii) the date of the 2025 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date. Read SEC document |
| February 13, 2024 Filed Feb 21, 2024 00:27 UTC Amendment |
Derynck Mika KDirector
|
GrantStock Option (right to buy) · Derivative | 23,364 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001415889-24-004486 · form4a-02212024_120231.xml · derivative · entry 1 Derynck Mika K · CIK 0001865125 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,364 Underlying: Common Stock · 23,364 shares Expires 2034-02-13 F1 · shares: The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant. F2 · derivative.exercise_date: 100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2024 annual meeting of the Issuer's stockholders or (ii) the date of the 2025 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date. F1 · derivative.underlying_shares: The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant. F1 · balance_after: The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant. Read SEC document |
| February 13, 2024 Filed Feb 21, 2024 00:24 UTC Amendment |
Ballal Rahul D.Director
|
GrantStock Option (right to buy) · Derivative | 23,364 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001415889-24-004482 · form4a-02212024_120256.xml · derivative · entry 1 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,364 Underlying: Common Stock · 23,364 shares Expires 2034-02-13 F1 · shares: The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant. F2 · derivative.exercise_date: 100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2024 annual meeting of the Issuer's stockholders or (ii) the date of the 2025 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date. F1 · derivative.underlying_shares: The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant. F1 · balance_after: The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant. Read SEC document |
| February 13, 2024 Filed Feb 21, 2024 00:35 UTC Amendment |
Phillips Andrew JohnDirector
|
GrantStock Option (right to buy) · Derivative | 23,364 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001415889-24-004493 · form4a-02212024_120239.xml · derivative · entry 1 Phillips Andrew John · CIK 0001921956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,364 Underlying: Common Stock · 23,364 shares Expires 2034-02-13 F1 · shares: The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant. F2 · derivative.exercise_date: 100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2024 annual meeting of the Issuer's stockholders or (ii) the date of the 2025 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date. F1 · derivative.underlying_shares: The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant. F1 · balance_after: The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant. Read SEC document |
| February 13, 2024 Filed Feb 21, 2024 00:32 UTC Amendment |
Heyman Richard A.Director
|
GrantStock Option (right to buy) · Derivative | 29,205 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001415889-24-004490 · form4a-02212024_120255.xml · derivative · entry 1 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,205 Underlying: Common Stock · 29,205 shares Expires 2034-02-13 F1 · shares: The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant. F2 · derivative.exercise_date: 100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2024 annual meeting of the Issuer's stockholders or (ii) the date of the 2025 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date. F1 · derivative.underlying_shares: The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant. F1 · balance_after: The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant. Read SEC document |
| February 13, 2024 Filed Feb 21, 2024 00:30 UTC Amendment |
Gupta RishiDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 23,364 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001415889-24-004488 · form4a-02212024_120247.xml · derivative · entry 1 Gupta Rishi · CIK 0001537370 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,364 Underlying: Common Stock · 23,364 shares Expires 2034-02-13 F1 · shares: The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant. F2 · derivative.exercise_date: 100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2024 annual meeting of the Issuer's stockholders or (ii) the date of the 2025 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date. F1 · derivative.underlying_shares: The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant. F1 · balance_after: The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant. Read SEC document |
| February 13, 2024 Filed Feb 21, 2024 00:26 UTC Amendment |
Bauer JakeDirector
|
GrantStock Option (right to buy) · Derivative | 23,364 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001415889-24-004484 · form4a-02212024_120202.xml · derivative · entry 1 Bauer Jake · CIK 0001654909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,364 Underlying: Common Stock · 23,364 shares Expires 2034-02-13 F1 · shares: The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant. F2 · derivative.exercise_date: 100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2024 annual meeting of the Issuer's stockholders or (ii) the date of the 2025 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date. F1 · derivative.underlying_shares: The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant. F1 · balance_after: The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant. Read SEC document |
| February 06, 2024 Filed Feb 9, 2024 01:47 UTC |
Patel AnishCHIEF OPERATING OFFICER
|
SaleCommon Stock | 4,875 | $15.11 | $73,658.33 |
DisclosureSEC source: 0001415889-24-003122 · form4-02092024_010243.xml · nonDerivative · entry 1 Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,347 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.07 to $15.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:29 UTC |
5AM Partners VI, LLC10% owner
5AM Ventures VI, L.P.10% owner
5AM Opportunities I (GP), LLC10% owner
5AM Opportunities I, L.P.10% owner
PARMAR KUSH10% owner
Schwab Andrew J.10% owner
|
SaleCommon Stock | 82,813 | $15.00 | $1,242,195.00 |
DisclosureSEC source: 0001415889-24-002295 · form4-02022024_090230.xml · nonDerivative · entry 2 5AM Partners VI, LLC · CIK 0001829051 · 10% owner 5AM Ventures VI, L.P. · CIK 0001753037 · 10% owner 5AM Opportunities I (GP), LLC · CIK 0001790778 · 10% owner 5AM Opportunities I, L.P. · CIK 0001753000 · 10% owner PARMAR KUSH · CIK 0001664281 · 10% owner Schwab Andrew J. · CIK 0001598549 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By 5AM Opportunities I, L.P. Disclosed balance after: 771,983 F2 · ownership.nature: The shares are directly held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are the managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Dr. Parmar and Mr. Schwab disclaims beneficial ownership of such shares, except to the extent of its or his respective pecuniary interest therein. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:29 UTC |
5AM Partners VI, LLC10% owner
5AM Ventures VI, L.P.10% owner
5AM Opportunities I (GP), LLC10% owner
5AM Opportunities I, L.P.10% owner
PARMAR KUSH10% owner
Schwab Andrew J.10% owner
|
SaleCommon Stock | 417,187 | $15.00 | $6,257,805.00 |
DisclosureSEC source: 0001415889-24-002295 · form4-02022024_090230.xml · nonDerivative · entry 1 5AM Partners VI, LLC · CIK 0001829051 · 10% owner 5AM Ventures VI, L.P. · CIK 0001753037 · 10% owner 5AM Opportunities I (GP), LLC · CIK 0001790778 · 10% owner 5AM Opportunities I, L.P. · CIK 0001753000 · 10% owner PARMAR KUSH · CIK 0001664281 · 10% owner Schwab Andrew J. · CIK 0001598549 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By 5AMVentures VI, L.P. Disclosed balance after: 3,888,992 F1 · ownership.nature: The shares are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VI and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VI. Each of Partners VI, Dr. Parmar and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Read SEC document |
| January 30, 2024 Filed Feb 2, 2024 01:10 UTC |
Heyman Richard A.Director
|
SaleCommon Stock | 1,270 | $16.41 | $20,839.56 |
DisclosureSEC source: 0001415889-24-002220 · form4-02022024_010213.xml · nonDerivative · entry 1 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,010 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 17, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $16.10 to $16.68. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 21:22 UTC |
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001415889-24-002127 · form4-02012024_020241.xml · derivative · entry 4 Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 284,550 Underlying: Common Stock · 12,000 shares Expires 2030-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F4 · derivative.exercise_date: The option, originally for 344,550 shares, is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on May 3, 2020. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 21:22 UTC |
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 12,000 | $15.85 | $190,256.40 |
DisclosureSEC source: 0001415889-24-002127 · form4-02012024_020241.xml · nonDerivative · entry 2 Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.58 to $16.375. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.